Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Jun 12, 2014 4:12pm
155 Views
Post# 22655151

RE:When insiders buy stock

RE:When insiders buy stockReally good points ColdNewfie.

At the end of the day it's going to be about wether rvx-208 works and for me at this stage I see huge possibilities regarding plaque regression, Mace reduction, diabetes and Alheimers treatment and the on the Zenith side almost infinite possibilities because they are only exploring 5 or 6 specific gene factories at this stage but this can just continue. It's like software development at this stage.

I'm long, always have been and will remain.

I still feel strongly that insiders putting up their own money and in particular the NGN involvement in the PP signals strong belief in rvx-206 and the underlying science. Keep in mind that the development does not stop there. Also, with the 4 month hold it is a strong signal that insiders expect a big gain soon by at least September when they can cash in.

Cheers
Toinv


Bullboard Posts